PMID- 33389001 OWN - NLM STAT- MEDLINE DCOM- 20210804 LR - 20210804 IS - 1434-4726 (Electronic) IS - 0937-4477 (Linking) VI - 278 IP - 9 DP - 2021 Sep TI - Evaluating the safety of oral methylene blue during swallowing assessment: a systematic review. PG - 3155-3169 LID - 10.1007/s00405-020-06509-3 [doi] AB - OBJECTIVE: Methylene blue (MB) is frequently administered during fiberoptic endoscopic evaluation of swallowing (FEES) to enhance visualization of pharyngeal bolus transit. However, the safety of MB is being questioned since serious adverse events (AEs) such as hemodynamic instability, hemolysis, and serotonin syndrome were reported. The aim of this study is a systematic analysis of the literature to obtain an evidence-based overview of AEs due to oral administration of MB and to determine its safety as a food dye during swallowing assessment. METHODS: A systematic literature search was carried out in PubMed, Embase, and Cochrane Library. Two reviewers independently selected articles describing oral administration of MB as a main diagnostic/therapeutic intervention, dosage, and AEs. Expert opinions, conference papers, sample size < 10, and animal studies were excluded. Level of evidence of the included studies was determined. RESULTS: A total of 2264 unduplicated articles were obtained. Seventeen studies met the inclusion criteria with 100% agreement between the two reviewers. Among these, twelve studies were randomized controlled trials. In a pooled population of 1902 patients receiving oral MB, three serious AEs were reported related to MB. Non-serious AEs showed a dose-related trend and were usually mild and self-limiting. A meta-analysis could not be performed as studies were methodologically too heterogeneous. CONCLUSION: Serious AEs due to oral administration of MB are rare (n = 3, 0.16%). MB-related non-serious AEs are mild, self-limiting, and show a dose-related trend. These findings indicate that it is safe to use small amounts of MB as a food dye during swallowing examinations. CI - (c) 2021. Springer-Verlag GmbH Germany, part of Springer Nature. FAU - Tariq, Bina AU - Tariq B AUID- ORCID: 0000-0002-8476-9946 AD - Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands. bina.tariq@outlook.com. FAU - Simon, Sorina R AU - Simon SR AD - Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands. AD - School for Oncology and Developmental Biology, GROW, Maastricht University, Maastricht, The Netherlands. AD - Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands. FAU - Pilz, Walmari AU - Pilz W AD - Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands. AD - School for Mental Health and Neuroscience, MHeNs, Maastricht University, Maastricht, The Netherlands. FAU - Maxim, Andra AU - Maxim A AD - Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands. FAU - Kremer, Bernd AU - Kremer B AD - Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands. AD - School for Oncology and Developmental Biology, GROW, Maastricht University, Maastricht, The Netherlands. FAU - Baijens, Laura W J AU - Baijens LWJ AD - Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands. AD - School for Oncology and Developmental Biology, GROW, Maastricht University, Maastricht, The Netherlands. LA - eng PT - Journal Article PT - Review PT - Systematic Review DEP - 20210102 PL - Germany TA - Eur Arch Otorhinolaryngol JT - European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery JID - 9002937 RN - T42P99266K (Methylene Blue) SB - IM MH - *Deglutition MH - Humans MH - *Methylene Blue/adverse effects MH - Pharynx OTO - NOTNLM OT - Adverse events OT - Dysphagia OT - Fiberoptic endoscopic evaluation of swallowing OT - Methylene blue OT - Safety EDAT- 2021/01/04 06:00 MHDA- 2021/08/05 06:00 CRDT- 2021/01/03 20:36 PHST- 2020/09/24 00:00 [received] PHST- 2020/11/17 00:00 [accepted] PHST- 2021/01/04 06:00 [pubmed] PHST- 2021/08/05 06:00 [medline] PHST- 2021/01/03 20:36 [entrez] AID - 10.1007/s00405-020-06509-3 [pii] AID - 10.1007/s00405-020-06509-3 [doi] PST - ppublish SO - Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3155-3169. doi: 10.1007/s00405-020-06509-3. Epub 2021 Jan 2.